Johnson & Johnson was ordered by a St. Louis jury to pay more than
$110 million to a Virginia woman who says her ovarian cancer was caused
by the company’s
talcum powder products. Imerys Talc America, the company that provided the talc to J&J,
was also ordered by the jury to pay about $100,000.
Plaintiff Lois Slemp, 62, said she used J&J’s baby powder and
Shower to Shower talc products for more than 40 years before her diagnosis
with ovarian cancer in 2012. J&J didn’t warn women of studies
linking talc to ovarian cancer to protect the company’s image, one
of Slemp's attorneys told jurors.
Johnson & Johnson Accused of Failing to Warn the Public
There are thousands of lawsuits nationwide accusing Johnson & Johnson
of ignoring scientific studies linking its baby powder and Shower to Shower
products to ovarian cancer. The lawsuits allege that the company failed
to warn customers about the risk of using talc-based products.
The $110 million verdict is the eighth-largest jury award in the U.S. so
far in 2017, according to data compiled by Bloomberg. J&J plans to
appeal the verdict, just as it has appealed its other losses. A spokesperson
for the company said that they "will continue to defend the safety
of Johnson’s Baby Powder."
The case is
Slemp v. Johnson & Johnson, 1422-CC09326, Circuit Court, City of St. Louis, Missouri.
Fourth Talcum Powder Case Goes to Trial
Johnson & Johnson Loses $417 Million Verdict in California Talc Powder Case
Johnson & Johnson Loses Third Trial Over Talc Powder
Ovarian Cancer Linked to Talc-Based Powder